Drugs / Human umbilical cord-derived MSCs
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01420432 | Jan 2011 → Dec 2013 | ankylosing spondylitis | Shandong University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Human umbilical cord-derived MSCs | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01420432 ↗ |
| Modality | Cell therapy | “This study will evaluate the safety and effectiveness of MSC transplantation in the AS patients.” NCT01420432 ↗ |
| Route | Intravenous | “1.0E+6 MSC/kg, IV drop and repeat repeated after three months” NCT01420432 ↗ |